As the most common cause of pathologic jaundice in infants, biliary atresia is an inflammatory cholangiopathy that destroys the epithelial lining of bile ducts, disrupts bile flow, and promotes a fibrosing obstruction of extrahepatic bile ducts. The etiology of biliary atresia is yet to be defined, but the pathogenic mechanisms of the disease are tightly linked to a robust response of the immune system that targets the bile ducts. 1, 2 Among the elements of the system, CD8+ and natural killer (NK) lymphocytes have been shown to be key regulators of the biliary atresia phenotype in a mouse model of disease. 3, 4 The clinical and laboratory hallmarks of the disease are 
